Welcome to our dedicated page for Bwx Technologies SEC filings (Ticker: BWXT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWX Technologies, Inc. (NYSE: BWXT) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. BWXT files annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K that cover financial performance, material agreements, capital structure changes and governance matters related to its nuclear-focused manufacturing and engineering business.
BWXT’s Form 8-K filings illustrate the range of topics investors can track. Recent 8-Ks have reported quarterly financial results, including revenue and segment performance for Government Operations and Commercial Operations, and have furnished earnings press releases that explain non-GAAP measures such as adjusted EBITDA, non-GAAP earnings per share and free cash flow. Other 8-Ks describe executive leadership changes, such as appointments of senior finance and legal officers, and provide details on material definitive agreements.
Filings also document capital markets transactions. In 2025, BWXT filed an 8-K describing the issuance of 0% Convertible Senior Notes due 2030 under an indenture with a trustee, including the aggregate principal amount, guarantee structure by certain domestic subsidiaries, conversion conditions, maturity date and events of default. Another 8-K discusses the planned private offering of convertible senior notes and expectations regarding a new senior secured revolving credit facility, subject to market conditions and other factors.
Through this page, users can follow BWXT’s official disclosures about its nuclear-related operations, contracts and financial condition. Stock Titan enhances access to these documents with AI-powered summaries that highlight key terms in filings such as 10-K and 10-Q reports, and can help interpret complex sections on topics like segment performance, non-GAAP metrics, convertible notes and covenant structures. The page also links to insider and governance-related information reported in current reports, giving a consolidated view of BWXT’s regulatory record.
BWX Technologies, Inc. director Daniel L. Jablonsky received an automatic grant of 0.160 dividend equivalent rights tied to a previously awarded restricted stock unit grant. Each dividend equivalent right and related RSU represents a contingent right to receive one share of BWX Technologies common stock.
According to the deferral election, both the RSUs and the associated dividend equivalent rights will be delivered to Jablonsky proportionately over time, matching the delivery schedule of the underlying RSUs. This is a small, compensation-related, non-cash acquisition rather than an open-market trade.
Bertsch Jan reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Jan Bertsch received a grant of 31.5 Dividend Equivalent Rights tied to previously awarded restricted stock units. Each right represents a contingent right to receive one share of BWXT common stock. After this compensation-related award, Bertsch directly holds 2,207.01 Dividend Equivalent Rights.
BWX Technologies, Inc. director Gerhard F. Burbach reported an acquisition of 16.96 Dividend Equivalent Rights tied to existing restricted stock units. These rights were granted at a price of $0.00 per right and increase his total reported Dividend Equivalent Rights holdings to 758.30.
According to the filing, these Dividend Equivalent Rights accrue on six restricted stock unit grants for which Burbach has elected to defer receipt of the underlying common shares. Each restricted stock unit and each Dividend Equivalent Right represents a contingent right to receive one share of BWX common stock, to be delivered proportionately when the related units are settled.
Richardson John M reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies director John M. Richardson received a grant of 11.73 Dividend Equivalent Rights (DERs) tied to existing restricted stock units. Each DER represents a contingent right to receive one share of BWX Technologies common stock, mirroring dividends on deferred RSUs.
Following this grant, Richardson holds 323.96 Dividend Equivalent Rights directly. The DERs will be delivered proportionately with the underlying restricted stock units, reflecting a routine, compensation-related equity accrual rather than any open-market trading activity.
PIASECKI NICOLE WEYERHAEUSER reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Nicole Weyerhaeuser Piasecki received an automatic grant of 5.03 Dividend Equivalent Rights tied to existing deferred restricted stock units. Each right represents a contingent right to receive one share of BWX Technologies common stock, bringing her total reported dividend equivalent holdings to 46.81.
Melvin Leland D reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Melvin Leland received a grant of 10.95 Dividend Equivalent Rights (DERs) linked to existing restricted stock units. Following this grant, he holds 215.34 DERs directly. Each RSU and DER is a contingent right to receive one share of BWXT common stock, and, under his deferral election, the DERs will be delivered proportionately when the related RSUs are ultimately settled.
Krieg Kenneth J reported acquisition or exercise transactions in this Form 4 filing.
BWX Technologies, Inc. director Kenneth J. Krieg received a grant of 28.020 Dividend Equivalent Rights tied to existing deferred restricted stock units. After this award, he holds 1,420.220 of these rights. Each right represents a contingent right to receive one share of BWXT common stock, delivered in proportion to the related RSUs.
BWX Technologies, Inc. director James M. Jaska received a compensation-related grant of dividend equivalent rights tied to existing deferred restricted stock units. On this date, he acquired 20.9100 dividend equivalent rights, each representing a contingent right to receive one share of BWXT common stock. Following this award, his total holdings of these dividend equivalent rights increased to 1086.4400, which will be delivered proportionately over time with the underlying restricted stock units he has elected to defer.
The Vanguard Group amended its Schedule 13G to report zero beneficial ownership of BWX Technologies Inc common stock. The amendment states that on January 12, 2026 Vanguard underwent an internal realignment and certain subsidiaries will report beneficial ownership separately in reliance on SEC Release No. 34-39538. The filing lists 0 shares beneficially owned and 0% of the class, and is signed by Ashley Grim as Head of Global Fund Administration on 03/26/2026.
BWX Technologies, Inc. is asking stockholders to vote at its virtual 2026 Annual Meeting on April 30, 2026. Investors will elect ten directors to one‑year terms, approve an advisory vote on 2025 executive pay, and ratify Deloitte & Touche LLP as independent auditor for 2026.
The company highlights strong governance practices, including 90% independent directors, an independent board chair, a 12‑year director tenure limit, majority voting with a resignation policy, no poison pill and no dual‑class stock. All directors are elected annually and all key board committees are fully independent.
BWXT reports 2025 consolidated revenue of $3.2 billion, up 18% year over year, GAAP net income of $329 million, and adjusted EBITDA of $574.3 million. GAAP and non‑GAAP EPS were $3.58 and $4.01, respectively. The company returned $122.5 million to stockholders via $30.0 million of share repurchases and $92.5 million of dividends, and ended 2025 with a $7.3 billion backlog.